PHE News

New Q&A with Amitabh Chandra in STAT News

Precision Health Economics' Scientific Advisor Amitabh Chandra is interviewed on the subject of precision medicine pricing, in a new Q&A for STAT News.

READ MORE

Precision to Have Strong Presence at ISPOR Europe, October 29th to November 2nd, 2016

At ISPOR's 19th Annual European Congress, to be held from October 29th - November 2nd, 2016 in Vienna, Austria, Precision will have a very strong presence. Come visit the Precision team in Booths 1000/900/1001/901! In addition, please click the link below for complete details on Precision's upcoming ISPOR EU sessions and presentations.

READ MORE

Philipson To UN in Wall Street Journal: Don't Blow Up Patent System

In Tomas Philipson's latest op-ed published in the Wall Street Journal, he points out that restricting the patent system will make it harder, not easier, for the global poor to get medicines.

READ MORE

Goldman, Nussbaum and Linthicum in Health Affairs: Innovation Needed in Pricing and Value Measurement

In their new Health Affairs blog post, Dana Goldman, Sam Nussbaum and Mark Linthicum make the case for advancing pricing and value measurement innovation via the launch of the Innovation and Value Initiative (IVI).

READ MORE

Precision's Philipson Participates in AEI Panel on Price of Specialty Drugs

On Monday, September 12th, 2016 at AEI in Washington DC, health policy experts including Precision's Tomas Philipson discussed the issue of high drug prices.

READ MORE

Tomas Philipson in Forbes: EU vs. US Cancer Care-- You Get What You Pay For

In his latest Opinion for Forbes.com, Precision's Tomas Philipson illustrates some dramatic differences in determining cost-effectiveness in the EU vs. the US

READ MORE

PHE's Jason Shafrin Analyzes Value Frameworks for Pharmaceutical Commerce

Senior Research Economist Jason Shafrin provides an in-depth analysis of value frameworks in his new article for Pharmaceutical Commerce: "Value frameworks are here: What to do about them?"

READ MORE
 
  • Academic Insights at

    the Speed of Business

     
  • Intellectual Integrity

    Led by professors at elite research universities, we bring intellectual integrity, academic rigor, and a creative approach to the most challenging problems in heath care.

     
  • Real World Impact

    PHE recommendations have defined and changed national and international payment policies.

     
  • Unparalleled Influence

    We frequently appear in top-tier publications and media outlets-- our work reaches top decision makers and influences outcomes.

     
  • Evidence Generation and

    Commercial Excellence

    As part of Precision for Value, our academic approach to research can be linked with a tailored, commercial approach that demonstrates the value of innovative medications.

     
  • Academic Insights at

    the Speed of Business